Testimonials
Lobular breast cancer grade 3 and Diabetes Mellitus | Woman, age 48
The patient was diagnosed with breast cancer in December 2012. She heard ofGanod.. Read More
Angina pectoris, Diabetes Mellitus, Hypertension and Struma thyroidae | Woman, age 78
Before she started usingGanoderma Lucidum Spore Oil Softgels, this patients suga.. Read More
Breast cancer | Woman, age 66
This patient was diagnosed with breast cancer in January of 2011. She was operat.. Read More
Colon cancer with metastasis on the liver | Man, age 73
In 2009 he left breast was removed, however on a follow up examination in Septem.. Read More
Ganoderma Plantation Ganoderma Farm
Ganoderma Town

Protection Against Lung Cancer Patient Plasma-Induced Lymphocyte Suppression by Ganoderma Lucidum Po

 Background/Aims: This study was conducted to determine the potential of Ganoderma lucidum polysaccharides (Gl-PS) in protection against lung cancer patient plasma-induced suppression of lymphocytes. Lung cancer is a major cause of disease and loss of life in the United States and worldwide. Cancer cells release immunosuppressive mediators, such as PGE2, TGF-β, IL-10, and VEGF, to inhibit the immune response to escape from immune surveillance. Gl-PS has been shown to counteract this immune inhibition in an animal cell culture model, and thus to facilitate tumor control. The present study explored whether or not such an effect could also be demonstrated in human lung cancer patients. Methods: Immunofluorescence, flow cytometry, MTT, immunocytochemistry, and western blot analysis were used to assess lymphocyte activation with PHA. Results: The plasma of lung cancer patients suppressed proliferation, CD69 expression, and perforin and granzyme B production in lymphocytes upon activation by PHA, effects that were partially of fully reversed by Gl-PS. Conclusion: Lung cancer patient plasma-induced suppression of lymphocyte activation by phytohemagglutinin may be antagonized fully or partially by Gl-PS, an observation suggesting the potential of Gl-PS in cancer therapy. © 2014 S. Karger AG, Basel.

Ganoderma lucidum

  

Copyright © 2012 GANODERMATOWN.COM. All rights reserved.